Wird geladen...
Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
OBJECTIVE: Stereotactic body radiotherapy (SBRT) has been shown to improve overall survival in patients with advanced hepatocellular carcinoma. This study aimed to assess the cost-effectiveness of SBRT compared to sorafenib which is the only drug for advanced hepatocellular carcinoma. METHODS: A Mar...
Gespeichert in:
| Veröffentlicht in: | Radiat Oncol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4870794/ https://ncbi.nlm.nih.gov/pubmed/27193904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-016-0644-4 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|